(Q35986780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

eradication of infectious diseases

1 reference

Helicobacter pylori infectious disease

inferred from title

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Maria Pina Dore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Vincenza Tadeu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Bianca Are

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ida Mura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Giuseppe Fanciulli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Giovannino Massarelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

14 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterology research and practice

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

484591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

3 February 2020

copyright license

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Emerging therapies for the treatment of Helicobacter pylori infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Therapy of Helicobacter pylori: current status and issues

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Efficacy of ciprofloxacin in the eradication of Helicobacter pylori

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F484591

Eradication rate of Helicobacter pylori in dyspeptic patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patien

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359787

Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori

24 September 2018

1 reference

12 December 2020

Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice?

1 reference

12 December 2020

Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach

1 reference

12 December 2020

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

12 December 2020

Two-week eradication regimen for metronidazole-resistant Helicobacter pylori

1 reference

12 December 2020

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome

1 reference

12 December 2020

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

12 December 2020

Helicobacter pylori in sheep milk

1 reference

12 December 2020

Isolation of Helicobacter pylori from sheep-implications for transmission to humans

1 reference

12 December 2020

Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients

1 reference

12 December 2020

Ciprofloxacin in the treatment of Helicobacter pylori in patients with gastritis and peptic ulcer

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/484591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

release_wb3hbjvssfcitijndgrgdxs74q

3 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wb3hbjvssfcitijndgrgdxs74q

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

PubMed publication ID

22666234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22666234%20AND%20SRC:MED&resulttype=core&format=json